PRILENIA

prilenia-logo

Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. The company was founded in 2018 and is based in Israel, the Netherlands, and Boston.

#People #Financial #Event #Website #More

PRILENIA

Social Links:

Industry:
Biotechnology Health Care Life Science Pharmaceutical

Founded:
2018-01-01

Address:
Herzliya, Tel Aviv, Israel

Country:
Israel

Website Url:
http://www.prilenia.com

Total Employee:
11+

Status:
Active

Contact:
+972-77-5558482

Email Addresses:
[email protected]

Total Funding:
105.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Global Site Tag Sitelinks Search Box



Current Advisors List

geert-jan-mulder_image

Geert Jan Mulder Board Member @ Prilenia
Board_member
2020-06-03

michael-j-ginder_image

Michael J. Ginder Board Member @ Prilenia
Board_member
2021-11-01

daniel-geffken_image

Daniel Geffken Senior Financial Advisor @ Prilenia
Advisor
2020-03-01

Current Employees Featured

osnat-shoham_image

Osnat Shoham
Osnat Shoham Head Of Finance @ Prilenia
Head Of Finance
2021-12-01

michael-hayden_image

Michael Hayden
Michael Hayden Founder & CEO @ Prilenia
Founder & CEO
2020-06-01

Founder


michael-hayden_image

Michael Hayden

Investors List

sectoral-asset-management_image

Sectoral Asset Management

Sectoral Asset Management investment in Series B - Prilenia

talisman-capital_image

Talisman Capital Partners

Talisman Capital Partners investment in Series B - Prilenia

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series B - Prilenia

als-investment-fund_image

ALS Investment Fund

ALS Investment Fund investment in Series B - Prilenia

amplitude-venture-capital_image

Amplitude Venture Capital

Amplitude Venture Capital investment in Series B - Prilenia

sands-capital-ventures_image

Sands Capital Ventures

Sands Capital Ventures investment in Series B - Prilenia

morningside-venture-partners-edb8_image

Morningside Venture Partners

Morningside Venture Partners investment in Series B - Prilenia

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series A - Prilenia

morningside-technology-ventures_image

Morningside Venture Investments

Morningside Venture Investments investment in Series A - Prilenia

sectoral-asset-management_image

Sectoral Asset Management

Sectoral Asset Management investment in Series A - Prilenia

Key Employee Changes

Date New article
2020-06-03 Prilenia Therapeutics raises $62.5m, names Michael Hayden CEO

Official Site Inspections

http://www.prilenia.com Semrush global rank: 4.74 M Semrush visits lastest month: 1.97 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Prilenia" on Search Engine